MAP PHARMACEUTICALS, INC. Forms 3, 4 and 5: Restricted Stock Units and Performance Rights
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 55 rows, 55 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-03-01: Reporting owner CHAI CHRISTOPHER Y; Form 4; Security Restricted Stock Unit (RSU); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-03-01: Reporting owner CHAI CHRISTOPHER Y; Form 4; Security Restricted Stock Unit (RSU); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-03-01: Reporting owner NELSON TIMOTHY S; Form 4; Security Restricted Stock Unit (RSU); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2013-03-01: Reporting owner ARMER THOMAS A; Form 4; Security Restricted Stock Unit (RSU); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-03-01 | CHAI CHRISTOPHER Y Officer (SVP, Chief Financial Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,500 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | CHAI CHRISTOPHER Y Officer (SVP, Chief Financial Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,250 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −28,125 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,500 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,250 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | Friedman Charlene A Officer (SVP, Gen Counsel & Sec) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,500 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | Friedman Charlene A Officer (SVP, Gen Counsel & Sec) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,250 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Chief Business Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,500 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | GIANAKAKOS ANASTASIOS Officer (SVP, Chief Business Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,250 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,500 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,250 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,500 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,375 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,250 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −300 0 owned after | $0.00 | 2013-03-04 | |
| 2013-03-01 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −750 0 owned after | $0.00 | 2013-03-04 | |
| 2013-01-26 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Indirect · See footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,900 3,800 owned after | $0.00 | 2013-01-29 | |
| 2013-01-26 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 4,500 owned after | $0.00 | 2013-01-29 | |
| 2013-01-26 | GIANAKAKOS ANASTASIOS Officer (SVP, Chief Business Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 4,500 owned after | $0.00 | 2013-01-29 | |
| 2013-01-26 | CHAI CHRISTOPHER Y Officer (SVP, Chief Financial Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 4,500 owned after | $0.00 | 2013-01-29 | |
| 2013-01-26 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 4,500 owned after | $0.00 | 2013-01-29 | |
| 2013-01-25 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Indirect · See footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,000 9,000 owned after | $0.00 | 2013-01-29 | |
| 2013-01-25 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,750 8,250 owned after | $0.00 | 2013-01-29 | |
| 2013-01-25 | GIANAKAKOS ANASTASIOS Officer (SVP, Chief Business Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,750 8,250 owned after | $0.00 | 2013-01-29 | |
| 2013-01-25 | CHAI CHRISTOPHER Y Officer (SVP, Chief Financial Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,750 8,250 owned after | $0.00 | 2013-01-29 | |
| 2013-01-25 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,750 8,250 owned after | $0.00 | 2013-01-29 | |
| 2013-01-25 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,375 28,125 owned after | $0.00 | 2013-01-29 | |
| 2012-06-07 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,125 3,375 owned after | $0.00 | 2012-06-08 | |
| 2012-01-26 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 6,750 owned after | $0.00 | 2012-01-27 | |
| 2012-01-26 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 6,750 owned after | $0.00 | 2012-01-27 | |
| 2012-01-26 | GIANAKAKOS ANASTASIOS Officer (SVP & Chief Business Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 1,307 owned after | $0.00 | 2012-01-27 | |
| 2012-01-26 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Indirect · See footnote | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,900 5,700 owned after | $0.00 | 2012-01-27 | |
| 2012-01-26 | CHAI CHRISTOPHER Y Officer (SVP & CFO) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 6,750 owned after | $0.00 | 2012-01-27 | |
| 2012-01-26 | Friedman Charlene A Officer (SVP President, Gen Counsel&Sec) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,250 6,750 owned after | $0.00 | 2012-01-27 | |
| 2012-01-25 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,000 11,000 owned after | $0.00 | 2012-01-27 | |
| 2012-01-25 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,000 11,000 owned after | $0.00 | 2012-01-27 | |
| 2012-01-25 | GIANAKAKOS ANASTASIOS Officer (SVP & Chief Business Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,000 11,000 owned after | $0.00 | 2012-01-27 | |
| 2012-01-25 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +37,500 37,500 owned after | $0.00 | 2012-01-27 | |
| 2012-01-25 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit (RSU) Derivative · Indirect · See footnote | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $0.00 | 2012-01-27 | |
| 2012-01-25 | CHAI CHRISTOPHER Y Officer (SVP & CFO) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,000 11,000 owned after | $0.00 | 2012-01-27 | |
| 2012-01-25 | Friedman Charlene A Officer (SVP President, Gen Counsel&Sec) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +11,000 11,000 owned after | $0.00 | 2012-01-27 | |
| 2011-08-04 | Borland Scott Officer (SVP, Neurology Franchise) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 3,165 owned after | $0.00 | 2011-08-08 | |
| 2011-08-04 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 6,331 owned after | $0.00 | 2011-08-08 | |
| 2011-08-04 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,250 7,122 owned after | $0.00 | 2011-08-08 | |
| 2011-08-04 holding as of filing | Borland Scott Officer (SVP, Neurology Franchise) | 3 | Resticted Stock Unit Derivative · Direct · (m) | Holding | no price filed | 2011-08-04 | ||
| 2011-08-04 holding as of filing | Borland Scott Officer (SVP, Neurology Franchise) | 3 | Restricted Stock Unit Derivative · Direct · (m) | Holding | no price filed | 2011-08-04 | ||
| 2011-08-04 holding as of filing | Borland Scott Officer (SVP, Neurology Franchise) | 3 | Restricted Stock Unit Derivative · Direct · (m) | Holding | no price filed | 2011-08-04 | ||
| 2011-08-04 holding as of filing | Borland Scott Officer (SVP, Neurology Franchise) | 3 | Restricted Stock Unit Derivative · Indirect · (m) | Holding | no price filed | 2011-08-04 | ||
| 2011-01-26 | Friedman Charlene A Officer (VP President, Gen Counsel &Sec) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2011-01-28 | |
| 2011-01-26 | GIANAKAKOS ANASTASIOS Officer (SVP, Cor & Business Dev) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2011-01-28 | |
| 2011-01-26 | CHAI CHRISTOPHER Y Officer (Chief Financial Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2011-01-28 | |
| 2011-01-26 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2011-01-28 | |
| 2011-01-26 | ARMER THOMAS A Director, Officer (Chief Scientific Officer) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,000 9,000 owned after | $0.00 | 2011-01-28 | |
| 2010-02-02 | NELSON TIMOTHY S Director, Officer (President and CEO) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $0.00 | 2010-02-04 | |
| 2010-02-02 | KELLERMAN DONALD J Officer (SVP,Clinical Dev & Med Affairs) | 4 | Restricted Stock Unit (RSU) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,500 22,500 owned after | $0.00 | 2010-02-04 |